Placental fatty acid transfer: A key factor in fetal growth

Annals of Nutrition and Metabolism

Volumn 64, Issue 3-4, 2014, Pages 247-253

  Larqué, Elvira ^a   Pagán, Ana ^a   Prieto, María Teresa ^b   Blanco, José Eliseo ^b   Gil Sánchez, Alfonso ^b   Zornoza Moreno, Matilde ^b   Ruiz Palacios, María ^a   Gázquez, Antonio ^a   Demmelmair, Hans ^c   Parrilla, Juan José ^b   Koletzko, Berthold ^c  

^a UNIVERSITY OF MURCIA   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Fat; Insulin; Long chain polyunsaturated fatty acids; Placenta; Pregestational obesity

Indexed keywords

DOCOSAHEXAENOIC ACID C 13; FATTY ACID; INSULIN; LINOLEIC ACID C 13; LIPID; OLEIC ACID C 13; PALMITIC ACID C 13; STABLE ISOTOPE; UNCLASSIFIED DRUG; CARBON; DOCOSAHEXAENOIC ACID;

ARTICLE; CESAREAN SECTION; FATTY ACID TRANSPORT; FEMALE; FETUS; FETUS GROWTH; HUMAN; IN VIVO STUDY; INSULIN TREATMENT; LIMIT OF QUANTITATION; LIPID TRANSPORT; MASS FRAGMENTOGRAPHY; MATERNAL PLASMA; NONHUMAN; PERINATAL DEVELOPMENT; PLACENTAL TRANSFER; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PRIORITY JOURNAL; RISK FACTOR; BODY MASS; COHORT ANALYSIS; DIABETES, GESTATIONAL; DOWN REGULATION; FETAL MACROSOMIA; FETOMATERNAL TRANSFUSION; FETUS DEVELOPMENT; INSULIN RESISTANCE; MATERNAL NUTRITION; METABOLISM; NERVOUS SYSTEM DEVELOPMENT; NORWAY; OBESITY; PATHOPHYSIOLOGY; PLACENTA; PREGNANCY; PREGNANCY COMPLICATION;

BODY MASS INDEX; CARBON ISOTOPES; COHORT STUDIES; DIABETES, GESTATIONAL; DOCOSAHEXAENOIC ACIDS; DOWN-REGULATION; FATTY ACIDS; FEMALE; FETAL DEVELOPMENT; FETAL MACROSOMIA; HUMANS; INSULIN RESISTANCE; MATERNAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; MATERNAL-FETAL EXCHANGE; NEUROGENESIS; NORWAY; OBESITY; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS; RISK FACTORS;

EID: 84908564204     PISSN: 02506807     EISSN: 14219697     Source Type: Journal    
DOI: 10.1159/000365028     Document Type: Article

References (39)

1. Pedersen J: Diabetes and pregnancy: blood sugar of newborn infants during fasting and glucose administration. Nord Med 1952; 47: 1049.
2. Schwartz R, Gruppuso PA, Petzold K, Brambilla D, Hiilesmaa V, Teramo KA: Hyperinsulinemia and macrosomia in the fetus of the diabetic mother. Diabetes Care 1994; 17: 640-648.
3. Evers IM, de Valk HW, Mol BW, ter Braak EW, Visser GH: M acrosomia despite good glycaemic control in type I diabetic pregnancy: results of a nationwide study in the Netherlands. Diabetologia 2002; 45: 1484-1489.
4. Sewell MF, Huston-Presley L, Super DM, Catalano P: Increased neonatal fat mass, not lean body mass, is associated with maternal obesity. Am J Obstet Gynecol 2006; 195: 1100-1103.
5. Tallarigo L, Giampietro O, Penno G, Miccoli R, Gregori G, Navalesi R: Relation of glucose tolerance to complications of pregnancy in nondiabetic women. N Engl J Med 1986; 315: 989-992.
6. Catalano PM, Farrell K, Thomas A, Huston-Presley L, Mencin P, de Mouzon SH, Amini SB: Perinatal risk factors for childhood obesity and metabolic dysregulation. Am J Clin Nutr 2009; 90: 1303-1313.
7. Lao TT, Tam KF: Maternal serum ferritin and gestational impaired glucose tolerance. Diabetes Care 1997; 20: 1368-1369.
8. Gauster M, Hiden U, Blaschitz A, Frank S, Lang U, Alvino G, Cetin I, Desoye G, Wadsack C: Dysregulation of placental endothelial lipase and lipoprotein lipase in intrauterine growthrestricted pregnancies. J Clin Endocrinol Metab 2007; 92: 2256-2263.
9. Catalano PM, Presley L, Minium J, Hauguel-de Mouzon S: Fetuses of obese mothers develop insulin resistance in utero. Diabetes Care 2009; 32: 1076-1080.
10. Friis CM,Qvigstad E,Paasche Roland MC,Godang K,Voldner N,Bollerslev J,Henriksen T, Newborn body fat: associations with maternal metabolic state and placental size. PLoS One, 2013, 8, e57467.
11. Roland MC, Friis CM, Godang K, Bollerslev J, Haugen G, Henriksen T: Maternal factors associated with fetal growth and birth weight are independent determinants of placental weight and exhibit differential effects by fetal sex. PLoS One 2014; 9:e87303.
12. Clifton VL: Review: Sex and the human placenta: mediating differential strategies of fetal growth and survival. Placenta 2010; 31:S33-S39.
13. I llsley NP: Glucose transporters in the human placenta. Placenta 2000; 21: 14-22.
14. Jansson N, Rosario FJ, Gaccioli F, Lager S, Jones HN, Roos S, Jansson T, Powell TL: Activa tion of placental mTOR signaling and amino acid transporters in obese women giving birth to large babies. J Clin Endocrinol Metab 2013; 98: 105-113.
15. Jansson T, Aye IL, Goberdhan DC: The emerging role of mTORC1 signaling in placental nutrient-sensing. Placenta 2012; 33(suppl 2):e23-e29.
16. Herrera E, Ortega-Senovilla H: Disturbances in lipid metabolism in diabetic pregnancy-are these the cause of the problem? Best Pract Res Clin Endocrinol Metab 2010; 24: 515-525.
17. Schaefer-Graf UM, Meitzner K, Ortega-Senovilla H, Graf K, Vetter K, Abou-Dakn M, Herrera E: Differences in the im plications of maternal lipids on fetal metabolism and growth between gestational diabetes mellitus and control pregnancies. Diabet Med 2011; 28: 1053-1059.
18. Gil-Sanchez A, Koletzko B, Larque E: Current understanding of placental fatty acid transport. Curr Opin Clin Nutr Metab Care 2012; 15: 265-272.
19. Rebholz SL, Burke KT, Yang Q, Tso P, Woollett LA: Dietary fat impacts fetal growth and metabolism: uptake of chylomicron remnant core lipids by the placenta. Am J Physiol Endocrinol Metab 2011; 301:E416-E425.
20. Tewari V, Tewari A, Bhardwaj N: Histological and histochemical chang es in placenta of diabetic pregnant females and its comparison with normal placenta. Asian Pac J Trop Dis 2011; 1-4.
21. Pathmaperuma AN, Mana P, Cheung SN, Kugathas K, Josiah A, Koina ME, Broo mfield A, Delghingaro-Augusto V, Ellwood DA, Dahlstrom JE, Nolan CJ: Fatty acids alter glycerolipid metabolism and induce lipid droplet formation, syncytialisation and cytokine production in human trophoblasts with minimal glucose eff ect or interaction. Placenta 2010; 31: 230-239.
22. Hernandez Albadalejo I, Gá zquez A, Blanco JE, Parrilla JJ, Larqué E: A method for lipid droplet isolation from human placenta for further an alyses in clinical trials. Acta Obstet Gynecol Scand 2014, in press.
23. Visiedo F, Bugatto F, Sanchez V, Cozar-Castellano I, Bartha JL, Perdomo G: High glucose levels reduce fatty acid oxidation and increase triglyceride accumulation in human placenta. Am J Physiol Endocrinol Me tab 2013; 305:E205-E212.
24. Gil-Sanchez A, Larque E, Demmelmair H, Acien MI, Faber FL, Parrilla JJ, Koletzko B: Maternal-fetal in vivo transfer of [13C]docosahexaenoic and other fatty aci ds across the human placenta 12 h after maternal oral intake. Am J Clin Nutr 2010; 92: 115-122.
25. Haggarty P, Ashton J, Joynson M, Abramovich DR, Page K: Effect of maternal polyunsaturated fatty acid concentration on transport by the human placenta. Biol Neonate 1999; 75: 350-359.
26. Pagan A, Prieto-Sanchez MT, Blanco-Carnero JE, Gil-Sanchez A, Parrilla JJ, Demmelmair H, Kol etzko B, Larque E: Materno-fetal transfer of docosahexaenoic acid is impaired by gestational diabetes mellitus. Am J Physiol Endocrinol Metab 2013; 305:E826-E833.
27. Pastromas S, Terzi AB, Touso ulis D, Koulouris S: Postprandial lipemia: an under-recognized atherogenic factor in patients with diabetes mellitus. Int J Cardiol 2008; 126: 3-12.
28. Thomas B, Ghebremeskel K, Lowy C, Min Y , Crawford MA: Plasma AA and DHA levels are not compromised in newly diagnosed gestational diabetic women. Eur J Clin Nutr 2004; 58: 1492-1497.
29. Saben J, Zhong Y, Gomez-Acevedo H, Thakali K M, Borengasser SJ, Andres A, Shankar K: Early growth response protein-1 mediates lipotoxicity-associated placental inflammation: role in maternal obesity. Am J Physiol Endocrinol Metab 2013; 305:E1-E14.
30. Min Y, Ghebremeskel K, Lowy C, Thomas B, Crawford MA: Adverse effect of obesity on red cell membrane arachidonic and docosahexaenoic acids in gestational diabetes. Diabetologia 2004; 47: 75-81.
31. Wijendran V,Bendel RB,Couch SC,Philipson EH,Cheruku S,Lammi-Keefe CJ, Fetal erythrocyte phospholipid polyunsaturated fatty acids are altered in pregnancy complicated with gestational diabetes mellitus. Lipids, 2000, 35, 927-931.
32. Magnusson AL, Waterman IJ, Wennergren M, Jansson T, Powell TL: Triglyceride hydrolase activities and expression of fatty acid binding proteins in the human placenta in pregnancies complicated by intrauterine growth restriction and diabetes. J Clin Endocrinol Metab 2004; 89: 4607-4614.
33. Lindegaard ML, Damm P, Mathiesen ER, Nielsen LB: Placental triglyceride ac cumulation in maternal type 1 diabetes is associated with increased lipase gene expression. J Lipid Res 2006; 47: 2581-2588.
34. Dube E, Gravel A, Martin C, Desparois G, Moussa I, Ethier-Chiass on M, Forest JC, Giguere Y, Masse A, Lafond J: Modulation of fatty acid transport and metabolism by maternal obesity in the human full-term placenta. Biol Reprod 2012; 87: 14, 1-11.
35. Radaelli T, Lepercq J, Varastehpour A, Basu S, Catalano PM, Hauguel-De Mouzon S: Differential regulation of genes for fetoplacental lipid pathways in pregnancy with gestational and type 1 diabetes mellitus. Am J Obstet Gynecol 2009; 201: 209.e201-209.e210.
36. Coe NR, Smith AJ, Frohnert BI, Watkins PA, Bernlohr DA: The fatty acid transport protein (FATP1) is a very long chain acyl-CoA synthetase. J Biol Chem 1999; 274: 36300-36304.
37. Larque E, Demmelmair H, Gil-Sanchez A, Prieto-Sanchez MT, Blanco JE, Pagan A, Faber FL, Zamora S, Parrilla JJ, Koletzko B: Placental transfer of fatty acids and fetal implications. Am J Clin Nutr 2011; 94: 1908S-1913S.
38. Larque E, Krauss-Etschmann S, Campoy C, Hartl D, Linde J, Klingler M, Demmelmair H, Cano A, Gil A, Bondy B, Koletzko B: Docosahexaenoic acid supp ly in pregnancy affects placental expression of fatty acid transport proteins. Am J Clin Nutr 2006; 84: 853-861.
39. Scifres CM, Chen B, Nelson DM, Sadovsky Y: Fatty acid binding protein 4 regulat es intracellular lipid accumulation in human trophoblasts. J Clin Endocrinol Metab 2011; 96:E1083-E1091.